Nevro Stock Performance Shares of NVRO stock opened at $5.85 on Monday. Nevro Corp. has a 12 month low of $3.17 and a 12 month high of $11.65. The company has a debt-to-equity ratio of 0.67, a ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of ...

Scavilla confirmed the acquisition of Nevro Corporation for $250 million, expanding Globus Medical's reach into the musculoskeletal market, particularly in neuromodulation technology and chronic ...

The bioelectric medicine market is growing at a CAGR of approximately 6-8% during the forecast period. The primary factors ...

O'Boyle is an Independent Director at Outset Medical, Inc., an Advisor at HighCape Capital Acquisition Corp. II and an Advisor at HighCape Partners Management LLC. He is on the Board of Directors at ...

The acquisition of Nevro Corporation is seen as a strategic move to expand into a $3 billion market space, enhancing Globus Medical Inc (NYSE:GMED)'s reach in the musculoskeletal market.

Outset Medical, Inc. (Nasdaq: OM) ("Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of ...

In April, we completed the purchase of all shares of the Nevro Corporation for an all cash transaction of $250 million the acquisition of Nevro further expands our reach into the musculoskeletal ...

Most recently, Mr. Galligan served as Chief Financial Officer at Nevro Corp., a medical device company in the implantable spinal cord stimulation market. During his 10-year tenure at Nevro ...

The MRI-safe neurostimulation systems market is poised for significant transformation, projected to more than double in value from USD 319.5 million in 2025 to USD 634.3 million by 2035, growing at a ...